Showing results (71-80 of 253) with videos related to

Sort By:
Pageof 26
Cytotherapy|September 10, 2025
Overcoming barriers to referral for CAR T-cell therapy in patients with non-Hodgkin aggressive B-cell lymphomas: A Delphi consensusStefano Luminari, Annalisa Chiappella, Alice Di Rocco, et al.
Cancer Medicine|April 23, 2020
How many chronic myeloid leukemia patients who started a frontline second-generation tyrosine kinase inhibitor have to switch to a second-line treatment? A retrospective analysis from the monitoring registries of the italian medicines agency (AIFA)Massimo Breccia, Pier Paolo Olimpieri, Odoardo Olimpieri, et al.
Biology of Blood and Marrow Transplantation : Journal of the American Society for Blood and Marrow Transplantation|May 14, 2017
Haploidentical Allogeneic Hematopoietic Cell Transplantation for Multiple Myeloma Using Post-Transplantation Cyclophosphamide Graft-versus-Host Disease ProphylaxisLuca Castagna, Alberto Mussetti, Raynier Devillier, et al.
Haematologica|July 2, 2013
Indications for hematopoietic stem cell transplantation in patients with follicular lymphoma: a consensus project of the EBMT-Lymphoma Working PartySilvia Montoto, Paolo Corradini, Martin Dreyling, et al.
Blood|January 17, 2004
Use of recombinant human growth hormone (rhGH) plus recombinant human granulocyte colony-stimulating factor (rhG-CSF) for the mobilization and collection of CD34+ cells in poor mobilizersCarmelo Carlo-Stella, Massimo Di Nicola, Raffaella Milani, et al.
British Journal of Haematology|January 9, 2013
A prospective, international phase 2 study of bortezomib retreatment in patients with relapsed multiple myelomaMaria T Petrucci, Pilar Giraldo, Paolo Corradini, et al.
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology|June 1, 2004
Graft-versus-lymphoma effect in relapsed peripheral T-cell non-Hodgkin's lymphomas after reduced-intensity conditioning followed by allogeneic transplantation of hematopoietic cellsPaolo Corradini, Anna Dodero, Francesco Zallio, et al.
Blood|May 10, 2003
Molecular remission after myeloablative allogeneic stem cell transplantation predicts a better relapse-free survival in patients with multiple myelomaPaolo Corradini, Michele Cavo, Henk Lokhorst, et al.
Clinical Cancer Research : an Official Journal of the American Association for Cancer Research|May 18, 2022
Phenotypic Composition of Commercial Anti-CD19 CAR T Cells Affects In Vivo Expansion and Disease Response in Patients with Large B-cell LymphomaChiara Monfrini, Federico Stella, Vanessa Aragona, et al.
Blood|February 13, 2009
Haploidentical stem cell transplantation after a reduced-intensity conditioning regimen for the treatment of advanced hematologic malignancies: posttransplantation CD8-depleted donor lymphocyte infusions contribute to improve T-cell recoveryAnna Dodero, Cristiana Carniti, Anna Raganato, et al.
Pageof 26